Literature DB >> 1464788

Sick building syndrome. Medical evaluation of two work forces.

D A Middaugh1, S M Pinney, D H Linz.   

Abstract

Sick building syndrome, characterized by upper respiratory irritative and central nervous system symptoms, is poorly understood. Building ventilation problems are frequent, although causative agent(s) are unknown. Few studies have addressed clinical characterization of symptomatic building occupants. Employees from two sites underwent standardized evaluation including medical history, physical examination and screening neurologic and neuropsychologic testing while acutely symptomatic. Both symptomatic and asymptomatic individuals were evaluated when one of the sites was evacuated. Baseline evaluation results for this group were available for comparison. Symptoms of both work forces mirrored those reported in the literature. General medical examination abnormalities were few and minor, while neurologic and neuropsychologic examinations documented mental status, cerebellar, and neurobehavioral deficits. There were statistically significant changes from baseline. Abnormalities were self-limited. Controlled evaluations of symptomatic sick building occupants should be performed to verify these findings.

Entities:  

Mesh:

Year:  1992        PMID: 1464788

Source DB:  PubMed          Journal:  J Occup Med        ISSN: 0096-1736


  3 in total

Review 1.  Occupational exposure to volatile anaesthetics: epidemiology and approaches to reducing the problem.

Authors:  C Byhahn; H J Wilke; K Westpphal
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Building health: an epidemiological study of "sick building syndrome" in the Whitehall II study.

Authors:  A F Marmot; J Eley; M Stafford; S A Stansfeld; E Warwick; M G Marmot
Journal:  Occup Environ Med       Date:  2006-04       Impact factor: 4.402

3.  Profile of patients with chemical injury and sensitivity.

Authors:  G Ziem; J McTamney
Journal:  Environ Health Perspect       Date:  1997-03       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.